MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines.
about
The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesisRole of apoptosis-related miRNAs in resveratrol-induced breast cancer cell death.Epigenetic control of autophagy by microRNAs in ovarian cancerMicroRNA-mRNA functional pairs for cisplatin resistance in ovarian cancer cells.The clinicopathological significance of miR-1307 in chemotherapy resistant epithelial ovarian cancer.Sjögren's syndrome-associated microRNAs in CD14(+) monocytes unveils targeted TGFβ signaling.MiR-1307 promotes ovarian cancer cell chemoresistance by targeting the ING5 expressionPatient-derived ovarian cancer xenografts re-growing after a cisplatinum treatment are less responsive to a second drug re-challenge: a new experimental setting to study response to therapy.Common Chemical Inductors of Replication Stress: Focus on Cell-Based Studies.miRNAs and long noncoding RNAs as biomarkers in human diseases.Oncogenes associated with drug resistance in ovarian cancer.Genomic alterations as mediators of miRNA dysregulation in ovarian cancer.Role of microRNAs in cancers of the female reproductive tract: insights from recent clinical and experimental discovery studies.MicroRNA-873 mediates multidrug resistance in ovarian cancer cells by targeting ABCB1.MicroRNA and gynecologic cancers.MiRNAs-mediated cisplatin resistance in breast cancer.Prediction of miRNA-disease Associations using an Evolutionary Tuned Latent Semantic Analysis.Identification of candidate biomarkers for epithelial ovarian cancer metastasis using microarray data.miR-300 regulates cellular radiosensitivity through targeting p53 and apaf1 in human lung cancer cells.
P2860
Q28271675-083FE4A7-0ABC-49A8-B9D7-36A3C63F5C3BQ33586833-A0846930-BA5F-4664-842B-C3B498DFEB7DQ33615837-DD9CDDB6-480E-48A8-833E-0CB31F132B92Q33764106-37B3B850-ACE3-4BD7-BF0F-922AEF63BBB1Q35666862-0C20D1FB-8289-4BEA-A90F-777408F3C478Q36867243-0B6E65F2-DC33-4E15-BA53-2F245F46BEA3Q37584834-16768006-3B12-448C-982C-5D02381E670BQ37702541-440A0D11-8D14-4E14-B833-1DE09B1A5554Q37729428-D2370A34-DEEA-4D22-846C-5A850E0CE617Q38088011-70F0EA13-9120-4FE6-8027-79B15965AB03Q38226577-A92C4242-C052-4003-9883-FF6E61A1E28EQ38256465-474B3FB6-AE60-4CC1-92F4-9558ECB23198Q38258014-D3B87FBA-BBA2-44E3-B5A7-D0C448764741Q38796136-FF80F6E2-B31F-40CD-B377-009DF6518F15Q38813155-4A08CD07-B189-42A6-94FF-7A9E7352F283Q38905681-657C11FD-1707-4C31-B74D-ACD90E191229Q41621167-78B4F32E-75B7-44B7-951C-6F1C77244625Q41701842-0D1427BF-36A8-41FE-8610-400FF551A732Q47818301-9127E257-D242-48C5-86FC-01102E7610C7
P2860
MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
MicroRNA signature of cis-plat ...... ive ovarian cancer cell lines.
@ast
MicroRNA signature of cis-plat ...... ive ovarian cancer cell lines.
@en
type
label
MicroRNA signature of cis-plat ...... ive ovarian cancer cell lines.
@ast
MicroRNA signature of cis-plat ...... ive ovarian cancer cell lines.
@en
prefLabel
MicroRNA signature of cis-plat ...... ive ovarian cancer cell lines.
@ast
MicroRNA signature of cis-plat ...... ive ovarian cancer cell lines.
@en
P2093
P2860
P356
P1476
MicroRNA signature of cis-plat ...... ive ovarian cancer cell lines.
@en
P2093
Arooshi Kumar
Parag P Shah
Sham S Kakar
Shesh N Rai
Siva K Panguluri
Smriti Kumar
P2860
P2888
P356
10.1186/1757-2215-4-17
P577
2011-09-22T00:00:00Z
P5875
P6179
1014419769